Dianfu Li

Dianfu Li


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2022 in Frontiers in Bioengineering and Biotechnology
Verified
Journal Article
Open access
WGWanying Gao
Wanying Gao
CWChunyan Wang
Chunyan Wang
QLQiwei Li
Qiwei Li
XZXijing Zhang
Xijing Zhang
JYJianmin Yuan
Jianmin Yuan
ZGZhongze Gu
Zhongze Gu
Organ-on-a-chip (OOC) is a new type of biochip technology. Various types of OOC systems have been developed rapidly in the past decade and found important applications in drug screening and precision medicine. However, due to the complexity in the structure of both the chip-body itself and the engineered-tissue inside, the imaging and analysis of OOC have still been a big challenge for biomedical researchers. Considering that medical imaging is moving towards higher spatial and temporal resolution and has more applications in tissue engineering, this paper aims to review medical imaging methods, including CT, micro-CT, MRI, small animal MRI, and OCT, and introduces the application of 3D printing in tissue engineering and OOC in which medical imaging plays an important role. The achievements of medical imaging assisted tissue engineering are reviewed, and the potential applications of medical imaging in organoids and OOC are discussed. Moreover, artificial intelligence - especially deep learning - has demonstrated its excellence in the analysis of medical imaging; we will also present the application of artificial intelligence in the image analysis of 3D tissues, especially for organoids developed in novel OOC systems.

1 June 2021 in Journal of Nuclear Cardiology
Verified
Journal Article
Closed access
CWCheng Wang
Cheng Wang
JSJianzhou Shi
Jianzhou Shi
JGJiacheng Ge
Jiacheng Ge
HTHaipeng Tang
Haipeng Tang
ZHZhuo He
Zhuo He
WZWeihua Zhou
Weihua Zhou

1 October 2020 in Journal of Nuclear Cardiology
Verified
Journal Article
Closed access
CWCheng Wang
Cheng Wang
HTHaipeng Tang
Haipeng Tang
FZFubao Zhu
Fubao Zhu
ZJZhixin Jiang
Zhixin Jiang
JSJianzhou Shi
Jianzhou Shi
WZWeihua Zhou
Weihua Zhou

1 October 2017 in Journal of Nuclear Cardiology
Verified
Journal Article
Closed access
WZWeihua Zhou
Weihua Zhou
ZJZhixin Jiang
Zhixin Jiang
JCJi Chen
Ji Chen
EGErnest V. Garcia
Ernest V. Garcia
DLDianfu Li
Dianfu Li

13 December 2023 in ESC Heart Failure
Verified
Journal Article
Open access
WCWenyi Cai
Wenyi Cai
ZFZhang Fang
Zhang Fang
ZTZhiqiang Tian
Zhiqiang Tian
DLDianfu Li
Dianfu Li
KTKangting Tang
Kangting Tang
Aims: This study aimed to investigate the causal association of aspirin consumption with the risk of heart failure. Methods: Our study included a total of 218 208 individuals, with 23 397 cases of heart failure. Genetic summary data on the association between single-nucleotide polymorphisms (SNPs) and aspirin consumption were obtained from a large-scale genome-wide association study involving 462 933 individuals, of which 61 702 people were taking aspirin. After the exclusion of critical confounding factors, we assessed the final and independent association between the aspirin consumption and the risk of heart failure using 3 two-sample Mendelian randomization (MR) methods-inverse variance weighted (IVW), weighted-median, and MR-Egger regression. Sensitivity analyses and directionality test were employed to further validate the stability of the results. Results: After excluding the SNPs that exhibited associations with potential confounders and harmonizing the data, a total of 32 SNPs were finally selected for MR analysis from the initially identified 60 SNPs that displayed strong associations with the exposure. The results of the main method (IVW) showed a significant positive association between aspirin use and the occurrence of heart failure (OR [odds ratio]: 1.085; 95% CI [confidence interval]: 1.015–1.161; P = 0.017), although other methods did not showed statistically significant results (MR-Egger, OR: 1.211, 95% CI: 0.842–1.21, P = 0.896; weighted-median, OR: 1.087, 95% CI: 0.983–1.202, P = 0.105). Heterogeneity test, the MR-Egger intercept, and the funnel plot did not reveal any evidence of heterogeneity (Cochran's Q statistic = 29.263; P = 0.556) or horizontal pleiotropy (intercept = 0.007; P = 0.319). The ‘leave-one-out’ analysis indicated that no individual SNP exerted a dominant influence on the main estimate. Directionality test confirmed the accuracy of the causal relationship between exposure and outcome direction in our data. Conclusions: Our results support a potential positive causal relationship between aspirin consumption and the occurrence of heart failure.

9 May 2019 in Electrophoresis
Verified
Journal Article
Closed access
PDF file
QHQiong Huang
Qiong Huang
ZGZhi Geng
Zhi Geng
TCTao Chen
Tao Chen
XCXiangjun Cheng
Xiangjun Cheng
HGHaitao Gu
Haitao Gu
RLRui Liu
Rui Liu